

| Package | Price per Dose | Price | |
|---|---|---|---|
| 180 pills | A$1.43 | A$343.61 A$257.70 | |
| 120 pills | A$1.82 | A$291.63 A$218.72 | |
| 90 pills | A$1.99 | A$239.65 A$179.74 | |
| 60 pills | A$2.32 | A$184.78 A$138.59 | |
| 30 pills | A$2.97 | A$118.37 A$88.77 | |
| 360 pills | A$2.32 | A$1,111.73 A$833.80 Free shipping | |
| 180 pills | A$2.40 | A$577.51 A$433.13 Free shipping | |
| 120 pills | A$2.47 | A$395.58 A$296.69 Free shipping | |
| 90 pills | A$2.73 | A$326.28 A$244.71 | |
| 60 pills | A$3.08 | A$245.42 A$184.07 | |
| 30 pills | A$3.83 | A$153.02 A$114.76 | |
| 180 pills | A$4.50 | A$1,079.97 A$809.98 Free shipping | |
| 120 pills | A$4.87 | A$779.65 A$584.74 Free shipping | |
| 90 pills | A$5.33 | A$638.15 A$478.61 Free shipping | |
| 60 pills | A$6.00 | A$479.33 A$359.50 Free shipping | |
| 30 pills | A$7.21 | A$288.74 A$216.56 |
Disclaimer: This information is for educational purposes and does not replace professional medical advice. In Australia, Remeron (mirtazapine) may require a prescription depending on local rules and a clinician’s assessment.
Sleep disturbance is a common companion of major depressive disorders, and persistent sleep issues can complicate recovery. Remeron, known generically as mirtazapine, is a antidepressant that belongs to a distinctive class called noradrenergic and specific serotonergic antidepressants (NaSSAs). It is often considered when sleep problems or appetite changes accompany mood symptoms, or when other antidepressants have not provided full relief.
As a medication option, mirtazapine works differently from many first-line antidepressants. Its action combines modulation of norepinephrine and serotonin signaling with receptor-level effects that promote sedation and appetite in some patients. The result can be a different balance of benefits and side effects compared with typical SSRI or SNRI therapy.\n
In Australia, prescribing decisions are individualized, balancing symptom profile, past responses to treatment, and safety considerations. Remeron may be selected when clinicians want to target sleep, anxiety, appetite, or agitation as part of a broader depressive spectrum. It is not generally a first-choice drug for everyone, but it can be particularly helpful for certain patients who experience insomnia and weight loss as part of their depression.
Compared with more commonly used antidepressants, Remeron tends to cause noticeable sedation for many patients. For some, this can be a welcomed effect that improves sleep and daily functioning; for others, daytime drowsiness or next-day sleepiness may be a drawback. Understanding this balance helps clinicians tailor therapy to individual needs, including coexisting conditions such as anxiety disorders or chronic pain where sleep interference plays a role.
Two practical realities anchor treatment planning: first, antidepressants typically require several weeks to demonstrate full benefit in mood, energy, and function; second, patient preferences and tolerability strongly influence ongoing use. This page provides a comprehensive look at Remeron to help patients understand how it might fit into a treatment plan, what to expect, and what to watch for in everyday use.
Remeron is primarily prescribed for major depressive disorder in adults, with clinicians sometimes considering it for older adults or people with complex symptom pictures who also report sleep problems or appetite changes. The medication may be chosen when sleep impairment is prominent and when weight restoration could be clinically beneficial. In some cases, clinicians may use mirtazapine as part of a plan to address treatment-resistant depression, particularly when there is a need to minimize agitation or insomnia that other antidepressants have not adequately managed.
When doctors compare Remeron with alternatives, several practical considerations come into play. Some patients tolerate SSRIs or SNRIs well but have residual sleep difficulties or anxiety; for these patients, Remeron might complement or even substitute a different agent. Others may prefer a drug with a sedating effect to help with sleep, or with a favorable effect on appetite and weight, especially if weight loss has been an issue. Conversely, for patients where sedation is undesirable or where there is a risk of excessive daytime sleepiness, clinicians may steer away from Remeron in favor of non-sedating options.
Physicians also weigh safety and interactions. Remeron can interact with other sedating medicines or substances that depress the central nervous system, and it carries its own profile of potential side effects such as drowsiness, weight change, and blood pressure effects. In pregnancy, liver disease, kidney disease, or in advanced age, the risk–benefit analysis changes, and closer monitoring is advised. If a patient has a history of bipolar disorder, clinicians assess the risk of triggering a mood episode when initiating or stopping antidepressants, including Remeron.
From a practical standpoint, the choice between Remeron and a different antidepressant often hinges on a combination of symptom targets, tolerability, prior response to similar medicines, and patient preference. A doctor will discuss goals such as sleep quality, appetite, anxiety level, energy, and mood, and may adjust treatment based on how these domains respond over weeks. If a patient experiences intolerable side effects or insufficient benefit, stepping to another agent or adding a non-antidepressant strategy (such as psychotherapy or a sleep-focused intervention) may be considered.
Importantly, the decision about which medication to use is highly individualized. A clinician will consider medical history, concomitant medications, potential drug interactions, and personal circumstances. Patients should engage in an open dialogue about expectations for sleep, appetite, mood, and daily functioning, and agree on a plan for monitoring progress and safety over time.
Remeron decreases depressive symptoms through a unique mechanism among antidepressants. It is categorized as a noradrenergic and specific serotonergic antidepressant (NaSSA). The drug blocks alpha-2 adrenergic receptors, which normally act as brakes on norepinephrine and serotonin release. By blocking these brakes, mirtazapine enhances signaling in certain brain circuits involved in mood and arousal.
In addition to this indirect boost to norepinephrine and serotonin, Remeron antagonizes several serotonin receptor subtypes, notably 5-HT2 and 5-HT3 receptors. This receptor profile is thought to contribute to improvements in sleep and appetite and may help reduce some anxiety-related symptoms. The net effect is different from SSRIs or SNRIs, which primarily increase serotonin or both serotonin and norepinephrine through reuptake inhibition without the same receptor-specific actions. Clinically, this can translate into distinct benefits for sleep and daytime energy in some patients.
Compared with tricyclic antidepressants (TCAs), which broadly affect multiple signaling pathways, Remeron’s targeted actions tend to produce a different balance of advantages and side effects. For example, some patients who experience sedation and weight gain with mirtazapine may find TCAs less tolerable due to anticholinergic effects or cardiovascular risks. On the other hand, SSRIs and SNRIs often improve mood and anxiety but may be associated with sleep disturbances or weight loss in certain individuals. The choice among these classes rests on symptom patterns, tolerability, and comorbid conditions.
In terms of onset, many antidepressants begin to show mood-related improvements after several weeks. Some patients on Remeron notice sleep-related benefits sooner, while others may take longer for mood changes to become evident. This nuanced timing is part of why clinicians tailor treatment plans to the patient’s evolving response over time, rather than expecting a rapid turnaround in all domains.
Additionally, Remeron’s metabolic and cardiovascular safety profile differs from other antidepressants. While weight gain is a recognized potential effect, some patients may experience weight stabilization or gain that helps with energy and overall function, particularly if poor appetite has been part of the depressive syndrome. As with all antidepressants, any concerns about mood shifts, sleep, appetite, or energy should prompt consultation with a clinician to reassess therapy and adjust as needed.
| Name | Primary use | Typical onset | Key advantage |
|---|---|---|---|
| Remeron (mirtazapine) | Major depressive disorder; sleep disturbance and appetite-related symptoms | Improvements may begin over a few weeks; full effect over several weeks | Sedation and appetite stimulation can aid sleep and weight gain where these are concerns |
| Sertraline | Depression and anxiety disorders | Typically several weeks for mood symptoms; some improvements earlier for anxiety | Generally favorable tolerability for many patients; strong anxiety symptom relief in some cases |
| Venlafaxine | Depression and certain anxiety disorders; neuropathic pain in some contexts | Weeks for mood symptoms; dose-dependent benefits for energy and anxiety | Broader norepinephrine involvement can help with energy and certain anxiety profiles |
| Amitriptyline | Depression; chronic pain and insomnia in some cases | Weeks for mood; sleep improvements may be observed in some patients | Good sleep-promoting effects and pain modulation, but higher anticholinergic burden |
Remeron is typically prescribed to be taken once daily, commonly at night, due to its sedating effects. The once-daily schedule helps align the medication’s calming influence with the body’s natural sleep pattern. Your clinician will tailor the dose and timing to your needs and monitor how you respond over time.
Tablets are swallowed whole with water. They should be taken exactly as prescribed; do not alter the dose without consulting a clinician. If you miss a dose, follow the guidance provided by your pharmacist or doctor rather than doubling up the next day.
Avoid drinking alcohol while taking Remeron, as both substances can amplify sedation and impair alertness. If you work night shifts or have unusual sleep needs, discuss timing with your prescriber to minimize daytime sleepiness while maintaining symptom control.
Remeron can interact with other medicines and supplements. Tell your healthcare provider about all medicines you take, including over-the-counter products, herbal remedies, and vitamins. Regular blood pressure checks may be advised during dose adjustments because of potential effects on blood pressure when starting or increasing the dose.
In the Australian context, if you have liver disease, kidney impairment, or are elderly, your clinician may adjust how you take Remeron and monitor you more closely for side effects or interactions. If you plan to become pregnant or are pregnant, discuss potential risks and alternatives with your clinician before continuing treatment.
Discontinuing Remeron abruptly can cause withdrawal-like symptoms or mood changes in some patients. If you need to stop or switch therapies, do so under medical supervision and with a clear taper plan to minimize discomfort and relapse risk.
Like all medicines, Remeron carries the possibility of side effects. Commonly reported effects include drowsiness, increased appetite, weight gain, dry mouth, and mild dizziness. Some people notice constipation or a warm sensation in the face and chest during dose changes. Most side effects are mild to moderate and tend to improve over time as the body adjusts.
Less common but important side effects can include low blood pressure on standing (orthostatic hypotension), agitation or restlessness, and unusual changes in mood or behavior. If mood changes worsen or thoughts of self-harm arise, seek urgent medical help or contact a clinician promptly. If you experience any severe or persistent side effects, report them to your healthcare provider so adjustments can be made.
Contraindications or cautionary factors include known hypersensitivity to mirtazapine or other components of the product, concurrent use of monoamine oxidase inhibitors (MAOIs) or a recent MAOI therapy, and certain severe liver conditions. Individuals with a history of bipolar disorder should be monitored for mood-switching when starting antidepressants, including Remeron. Always discuss your full medical history with your clinician before beginning therapy.
Special populations require careful consideration. In older adults, sedation and dizziness may raise fall risk, so safety measures and gradual dose adjustments are important. Pregnancy and breastfeeding decisions should involve a clinician who can weigh potential benefits against potential risks to the fetus or infant. If you have kidney or liver impairment, your doctor may adjust dosing and perform more frequent follow-up checks.
For safety reasons, Remeron should not be used with certain mood-stabilizing therapies or antidepressants without professional guidance. If you experience any signs of an allergic reaction (such as a rash, itching, swelling, severe dizziness, or trouble breathing), seek urgent medical attention. If you have concerns about drug interactions, contact your pharmacist or prescriber for a review of all medications you take.
Remeron can interact with other medicines in ways that affect safety or effectiveness. Avoid concurrent use with monoamine oxidase inhibitors (MAOIs) due to the potential for serious interactions. The combination with other central nervous system depressants, including certain sleep aids or alcohol, can enhance sedation and impair alertness. Be cautious with medicines that affect liver enzymes, as they may alter how Remeron is metabolized.
Compared with some antidepressants, Remeron’s interactions are shaped by its receptor profile and metabolic pathways. Certain anti-anxiety medicines or sedatives may intensify drowsiness when taken with Remeron. Always inform your healthcare provider about all prescriptions, over-the-counter drugs, and herbal supplements you use so they can assess risks and adjust therapy as needed.
Particular attention should be paid to potential interactions with medicines that influence blood pressure, heart rhythm, or electrolytes. If you notice unusual bleeding, severe dizziness, or a rapid heartbeat after starting Remeron, seek medical advice promptly. In case of planned surgery or upcoming anesthesia, inform your medical team that you are taking Remeron to ensure safe perioperative management.
Grapefruit and certain other foods or supplements sometimes interact with antidepressants by modulating liver enzymes. If your clinician suggests dietary considerations around Remeron, follow their guidance and discuss any questions you have about food or supplement timing in relation to the dose schedule.
In elderly adults, the sedating effects of Remeron may contribute to daytime sleepiness and falls. Clinicians often start at lower doses and monitor closely in this group. If falls or balance issues occur, a dose adjustment or change to another agent may be considered.
During pregnancy, the safety profile is evaluated on a case-by-case basis. If pregnancy is planned or confirmed, discuss the risks and benefits with your clinician to determine whether Remeron remains the best option or if an alternative antidepressant would be preferable.
For people with liver disease, dose adjustments and careful monitoring are typically advised because metabolism can be affected. Patients with significant hepatic impairment may require alternative therapies or modified dosing strategies. If you have kidney disease, dose considerations and monitoring for adverse effects are also important, as renal function can influence drug clearance.
If you have a history of seizures, glaucoma, or heart rhythm disorders, you should discuss these conditions with your clinician. While these conditions do not automatically preclude using Remeron, they can influence risk versus benefit and monitoring plans. Always disclose your full medical history when starting or stopping any antidepressant therapy.
In all populations, Remeron should be used with caution in combination with substances that depress the central nervous system or in environments with high risk for sedation-related accidents. If you have questions about safety in your circumstances, consult your clinician or pharmacist for a personalized assessment.
Your pharmacist and clinician are primary sources for individualized guidance about Remeron. The official patient information leaflet provides detailed safety, dosing, and interaction notes specific to the Australian context. For authoritative, government-regulated information, review materials from Australian regulatory bodies and national health resources, and bring any questions you have to your next appointment.
In clinical practice, ongoing evaluation is essential. If sleep, mood, energy, or appetite changes occur after starting Remeron, document these changes and discuss them with your clinician. Shared decision-making supports safer, more effective treatment as symptoms evolve over time.
Remember that this information is informational and not a substitute for medical advice. If you are unsure about anything related to Remeron, check the official leaflet or consult a healthcare professional. If you experience severe symptoms such as thoughts of self-harm or harm to others, seek immediate medical help.
For those seeking support resources, licensed healthcare providers and local pharmacies can offer patient information, counseling, and monitoring plans tailored to Australia’s healthcare system and your personal health needs.
Both medications can be effective for depression, but they work differently and have distinct side effect profiles. Remeron may be preferred if sleep problems or weight/appetite concerns are prominent, whereas sertraline is a common first-line choice with a long track record for anxiety and mood symptoms. A clinician can weigh your symptoms, past responses, and tolerability when guiding a choice.
Remeron’s receptor profile can promote sleep and reduce irritability in some patients, which may be advantageous when sleep disturbance is a primary concern. For anxiety, Remeron can be helpful for certain individuals, though responses vary. Your clinician will monitor how sleep and anxiety respond as therapy progresses and may adjust the regimen accordingly.
Switching between antidepressants should be done under medical supervision to manage potential withdrawal or interaction effects. A clinician may plan a taper of the first medicine while introducing Remeron gradually. The time to noticeable mood improvement varies and is typically measured in weeks rather than days.
Generic mirtazapine is available and shares the same active ingredient as Remeron. Brand names like Remeron may differ in packaging or dosing devices, but the therapeutic effect is the same when used as prescribed. Always follow your clinician’s instructions and the information on the patient leaflet.
Reasons include comorbid sleep disturbance, appetite concerns, prior life circumstances, and tolerability patterns. If sleep and appetite changes are central to the depressive picture, Remeron’s profile may align well with treatment goals. Side effect considerations and drug interaction potential also influence the choice.
Discontinuation should generally be gradual unless your clinician directs otherwise. Abrupt stopping can cause withdrawal-like symptoms or mood changes in some patients. A taper plan helps mitigate these risks and should be guided by a clinician.
Weight gain is a known possibility with Remeron and can be beneficial if an individual has lost weight or poor appetite due to depression. For others, weight gain may be undesirable. Discuss your weight goals and health profile with your clinician to weigh benefits and risks.
Data on use during pregnancy and breastfeeding are considered carefully against potential risks. If you are pregnant or planning pregnancy, speak with your clinician about potential alternatives and the safest options for you and the baby. Breastfeeding considerations should also be discussed with a healthcare professional.
Most people begin to notice changes over several weeks, though sleep or energy benefits may appear earlier for some individuals. It may take longer to see a full mood improvement, and your clinician will evaluate progress at follow-up visits to decide whether to continue, adjust, or switch therapy.
Alcohol can amplify drowsiness and sedation, so it is generally advised to limit or avoid alcohol while on Remeron. Discuss your alcohol use with your clinician, especially if sleep or daytime functioning is affected.
Remeron can be helpful in some cases of anxious depression because of its dual action on sleep and mood. However, responses are individual, and some patients may respond better to other agents specifically targeting anxiety symptoms. Your clinician will tailor the plan to your symptom profile.
Combining Remeron with benzodiazepines or other sleep medicines increases the risk of sedation and cognitive slowing. A clinician will assess whether a combination is appropriate and safe in your case, adjusting doses or exploring alternatives if necessary.
Bring a current list of all medications, supplements, and vitamins you take, including over-the-counter products. Note your sleep patterns, appetite changes, mood fluctuations, energy levels, and any previous antidepressants tried. This information helps your clinician tailor a plan and monitor progress effectively.
For comprehensive, Australia-specific information, consult the official patient information leaflet and speak with your pharmacist or clinician. Regulatory bodies and health authorities provide resources intended to support safe, informed use of antidepressant therapies, including Remeron (mirtazapine).
If you have concerns about starting or stopping Remeron, or about how it might fit with other treatments you are using, arrange a discussion with your healthcare provider. Medication choices should be revisited regularly as symptoms evolve and additional therapies—such as psychotherapy or sleep interventions—are integrated into the overall treatment plan.
14–21 days. Free from A$279.45 .
5–9 days. A$41.92
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
